Remo CRO


Parexel launches Patient Sensor Solution for clinical trial data collection

03.31 2017.

Parexel International, a global biopharmaceutical services provider, launched its patient sensor solution, a new offering that securely captures, transmits, stores and visualizes study subject data in clinical trials. Parexel’s offering, powered by the Perceptive MyTrials Analytics platform, enables an end-to-end services and technology solution that facilitates the remote collection of study subject data via medical devices. […] Details

Mylan names Daniel Gallagher chief legal officer

03.31 2017.

Mylan announced the appointment of Daniel M. Gallagher as chief legal officer. He will be joining the company on April 17, 2017. Gallagher joins Mylan from Patomak Global Partners, a consulting firm providing strategic advice, compliance consulting, and litigation and regulatory enforcement services, where he was president. From Nov. 2011 to Oct. 2015, Gallagher served as a commissioner of the U.S. […] Details

Burst Biologics initiates multicenter study in spinal fusion

03.31 2017.

Burst Biologics has received IRB approval to begin a multicenter prospective clinical study in spinal fusion patients. This study will be conducted using BioBurst Fluid, a cellular allograft derived from umbilical cord blood (UCB) which has shown very promising results in spinal fusion procedures. Fifteen clinical sites will participate throughout the U.S., with a total […] Details

Parker Institute, Bristol-Myers Squibb, Cancer Research Institute collaborate

03.31 2017.

The Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute (CRI) have announced a multi-year clinical research collaboration to coordinate and rapidly initiate clinical Immuno-Oncology (I-O) studies across the Parker Institute and CRI networks. Bristol-Myers Squibb will work closely with Parker Institute and CRI scientists and researchers, soliciting clinical research proposals from their networks and coordinating […] Details

AbbVie joins ORIEN Avatar Research Program

03.31 2017.

AbbVie, a global biopharmaceutical company, and M2Gen, a health informatics solutions company, announced that AbbVie has joined the Oncology Research Information Exchange Network (ORIEN) Avatar Research Program. Launched in April of 2016, the ORIEN Avatar Research Program fosters collaboration among key stakeholders in cancer research with the shared goal of discovering and developing novel therapies in […] Details

Icertis updates clinical trial agreement and budgeting solution

03.31 2017.

Icertis, a provider of enterprise contract management in the cloud, has announced an upgrade to the Icertis Clinical Trial Agreement and Budgeting solution designed to improve clinical trials contract management. Built on the Icertis Contract Management (ICM) platform, the solution speeds up clinical trial contracting while improving collaboration and compliance with CRO. “The pharmaceutical industry is under intense pressure […] Details